|
chronic kidney disease |
9 |
|
precision medicine |
8 |
|
genome sequencing |
7 |
|
genomic diversity |
7 |
|
hong kong genome project |
7 |
|
long read genome sequencing |
7 |
|
lupus nephritis |
7 |
|
population-based genome project |
7 |
|
rare disease |
7 |
|
short read genome sequencing |
7 |
|
covid-19 |
6 |
|
hepatitis b |
5 |
|
herpes zoster |
5 |
|
immunogenicity |
5 |
|
influenza |
5 |
|
invasive pneumococcal disease |
5 |
|
safety |
5 |
|
vaccine |
5 |
|
antiphospholipid antibodies |
4 |
|
long term |
4 |
|
outcomes |
4 |
|
renal replacement therapy |
4 |
|
third dose |
4 |
|
cardiovascular diseases |
3 |
|
challenging variants |
3 |
|
non-coding variants |
3 |
|
pseudogenes |
3 |
|
rare diseases |
3 |
|
repeat expansions |
3 |
|
risk factors |
3 |
|
structural variants |
3 |
|
systemic lupus erythematosus |
3 |
|
whole genome sequencing |
3 |
|
kidney transplantation |
2 |
|
asia |
1 |
|
diagnostics |
1 |
|
exome sequencing |
1 |
|
igg subclass |
1 |
|
immunofluorescence |
1 |
|
kidney biopsy |
1 |
|
monoclonal gammopathy of renal significance |
1 |
|
registry |
1 |
